BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Teng KY, Ghoshal K. Role of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver Fibrosis. Gene Expr 2015;16:155-62. [PMID: 26637395 DOI: 10.3727/105221615X14399878166078] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Wu X, Zhi F, Lun W, Deng Q, Zhang W. Baicalin inhibits PDGF-BB-induced hepatic stellate cell proliferation, apoptosis, invasion, migration and activation via the miR-3595/ACSL4 axis. Int J Mol Med 2018;41:1992-2002. [PMID: 29393361 DOI: 10.3892/ijmm.2018.3427] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
2 Penke LR, Peters-Golden M. Molecular determinants of mesenchymal cell activation in fibroproliferative diseases. Cell Mol Life Sci 2019;76:4179-201. [PMID: 31563998 DOI: 10.1007/s00018-019-03212-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
3 Jiang XP, Ai WB, Wan LY, Zhang YQ, Wu JF. The roles of microRNA families in hepatic fibrosis. Cell Biosci. 2017;7:34. [PMID: 28680559 DOI: 10.1186/s13578-017-0161-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
4 Tang PM, Zhang YY, Lan HY. LncRNAs in TGF-β-Driven Tissue Fibrosis. Noncoding RNA 2018;4:E26. [PMID: 30287731 DOI: 10.3390/ncrna4040026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
5 Guo J, Fang W, Sun L, Lu Y, Dou L, Huang X, Tang W, Yu L, Li J. Ultraconserved element uc.372 drives hepatic lipid accumulation by suppressing miR-195/miR4668 maturation. Nat Commun 2018;9:612. [PMID: 29426937 DOI: 10.1038/s41467-018-03072-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
6 Makhmudi A, Supanji R, Putra BP, Gunadi. The effect of APTR, Fn14 and CD133 expressions on liver fibrosis in biliary atresia patients. Pediatr Surg Int 2020;36:75-9. [PMID: 31549181 DOI: 10.1007/s00383-019-04582-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Teng KY, Barajas JM, Hu P, Jacob ST, Ghoshal K. Role of B Cell Lymphoma 2 in the Regulation of Liver Fibrosis in miR-122 Knockout Mice. Biology (Basel) 2020;9:E157. [PMID: 32650615 DOI: 10.3390/biology9070157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 He Z, Yang D, Fan X, Zhang M, Li Y, Gu X, Yang M. The Roles and Mechanisms of lncRNAs in Liver Fibrosis. Int J Mol Sci 2020;21:E1482. [PMID: 32098245 DOI: 10.3390/ijms21041482] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
9 Moran-Salvador E, Mann J. Epigenetics and Liver Fibrosis. Cell Mol Gastroenterol Hepatol 2017;4:125-34. [PMID: 28593184 DOI: 10.1016/j.jcmgh.2017.04.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 11.4] [Reference Citation Analysis]
10 Gong FH, Cheng WL, Wang H, Gao M, Qin JJ, Zhang Y, Li X, Zhu X, Xia H, She ZG. Reduced atherosclerosis lesion size, inflammatory response in miR-150 knockout mice via macrophage effects. J Lipid Res 2018;59:658-69. [PMID: 29463607 DOI: 10.1194/jlr.M082651] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
11 Xuan L, Sun L, Zhang Y, Huang Y, Hou Y, Li Q, Guo Y, Feng B, Cui L, Wang X, Wang Z, Tian Y, Yu B, Wang S, Xu C, Zhang M, Du Z, Lu Y, Yang BF. Circulating long non-coding RNAs NRON and MHRT as novel predictive biomarkers of heart failure. J Cell Mol Med 2017;21:1803-14. [PMID: 28296001 DOI: 10.1111/jcmm.13101] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 11.4] [Reference Citation Analysis]
12 Zhang Y, Luo G, Zhang Y, Zhang M, Zhou J, Gao W, Xuan X, Yang X, Yang D, Tian Z, Ni B, Tang J. Critical effects of long non-coding RNA on fibrosis diseases. Exp Mol Med 2018;50:e428. [PMID: 29350677 DOI: 10.1038/emm.2017.223] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
13 Gu YY, Dou JY, Huang XR, Liu XS, Lan HY. Transforming Growth Factor-β and Long Non-coding RNA in Renal Inflammation and Fibrosis. Front Physiol 2021;12:684236. [PMID: 34054586 DOI: 10.3389/fphys.2021.684236] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Kweon M, Kim JY, Jun JH, Kim GJ. Research Trends in the Efficacy of Stem Cell Therapy for Hepatic Diseases Based on MicroRNA Profiling. Int J Mol Sci 2020;22:E239. [PMID: 33383629 DOI: 10.3390/ijms22010239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Gabbia D, Carpi S, Sarcognato S, Cannella L, Colognesi M, Scaffidi M, Polini B, Digiacomo M, Esposito Salsano J, Manera C, Macchia M, Nieri P, Carrara M, Russo FP, Guido M, De Martin S. The Extra Virgin Olive Oil Polyphenol Oleocanthal Exerts Antifibrotic Effects in the Liver. Front Nutr 2021;8:715183. [PMID: 34671630 DOI: 10.3389/fnut.2021.715183] [Reference Citation Analysis]
16 Sovaila S, Purcarea A, Gheonea D, Ionescu S, Ciurea T. Cellular Interactions in the Human Fatty Liver. J Med Life 2019;12:338-40. [PMID: 32025251 DOI: 10.25122/jml-2019-1010] [Reference Citation Analysis]
17 Wang D, Chen F, Zeng T, Tang Q, Chen B, Chen L, Dong Y, Li X. Comprehensive biological function analysis of lncRNAs in hepatocellular carcinoma. Genes Dis 2021;8:157-67. [PMID: 33997162 DOI: 10.1016/j.gendis.2019.12.013] [Reference Citation Analysis]
18 Zhenghua G, Chaowen D, Tianxin X, Lili T, Hongbo X, Yanzhong P, Jie Z, Guoxin H. Effect of Dahuang Zhechong pills on long non-coding RNA growth arrest specific 5 in rat models of hepatic fibrosis. Journal of Traditional Chinese Medicine 2018;38:190-6. [DOI: 10.1016/j.jtcm.2018.04.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ganguly N, Chakrabarti S. Role of long non‑coding RNAs and related epigenetic mechanisms in liver fibrosis (Review). Int J Mol Med 2021;47:23. [PMID: 33495817 DOI: 10.3892/ijmm.2021.4856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Liang H, Pan Z, Zhao X, Liu L, Sun J, Su X, Xu C, Zhou Y, Zhao D, Xu B, Li X, Yang B, Lu Y, Shan H. LncRNA PFL contributes to cardiac fibrosis by acting as a competing endogenous RNA of let-7d. Theranostics 2018;8:1180-94. [PMID: 29464008 DOI: 10.7150/thno.20846] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 17.0] [Reference Citation Analysis]
21 DeOcesano-Pereira C, Machado RAC, Chudzinski-Tavassi AM, Sogayar MC. Emerging Roles and Potential Applications of Non-Coding RNAs in Glioblastoma. Int J Mol Sci 2020;21:E2611. [PMID: 32283739 DOI: 10.3390/ijms21072611] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
22 Lu J, Guo J, Liu J, Mao X, Xu K. Long Non-coding RNA MALAT1: A Key Player in Liver Diseases. Front Med 2022;8:734643. [DOI: 10.3389/fmed.2021.734643] [Reference Citation Analysis]
23 Hayes CN, Chayama K. MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma. Int J Mol Sci. 2016;17:280. [PMID: 26927063 DOI: 10.3390/ijms17030280] [Cited by in Crossref: 112] [Cited by in F6Publishing: 109] [Article Influence: 18.7] [Reference Citation Analysis]
24 Souza T, Trairatphisan P, Piñero J, Furlong LI, Saez-Rodriguez J, Kleinjans J, Jennen D. Embracing the Dark Side: Computational Approaches to Unveil the Functionality of Genes Lacking Biological Annotation in Drug-Induced Liver Injury. Front Genet 2018;9:527. [PMID: 30515189 DOI: 10.3389/fgene.2018.00527] [Reference Citation Analysis]